Lopinavir + Ritonavir

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Brands with this exact combination

BrandDoseManufacturer
KaletraAUCAESEUGBHKMXSGUS80 mg / 20 mg / 100 mg / 25 mg / 200 mg / 50 mgABBVIE CORPORATION
Lopinavir 133.3mg / Ritonavir 33.3mg capsulesAUESGB133.3 mg / 33.3 mg / 400 mg / 100 mg / 200 mg / 50 mgAbbvie Deutschland Gmbh & Co. Kg
Lopinavir and ritonavirUS200 mg / 50 mg / 80 mg / 20 mg / 100 mg / 25 mgAbbVie Inc.
LOPINAVIR AND RITONAVIR TABLETS USP 100MG/25MGHK—CHEMILL PHARMA LIMITED
LOPINAVIR/RITONAVIR VIATRISESEU100 mg / 25 mg / 200 mg / 50 mgViatris Limited
CLEVAMX—Ultra Laboratorios, S.A. de C.V.
KALETRA MG)/MLES400 mg / 100 mgAbbvie Deutschland Gmbh & Co. Kg
LOPINAVIR/RITONAVIR ACCORDES200 mg / 50 mgAccord Healthcare S.L.U.
RILONAEVOMX—Evolution Proces, S.A. de C.V.
DALOVIAMX—Hetero Labs Limited.
GADANMEMX—Laurus Labs Limited.
ritonavir + lopinavirAU——
KALETRA TABLETS lopinavir 200mg and ritonavir 50mg tablets bottleAU200 mg / 50 mgAbbvie Pty Ltd
KALETRA oral solution bottleAU80 mg/mL / 20 mg/mLAbbvie Pty Ltd

Same combination in other markets

These markets record products with the same active-ingredient combination. Identity only — not a recommendation that products are interchangeable.

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.